ArticleOncotarget2017

Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab.

Choong-Kun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.